TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/27/22 19:20 | 5/25/22 | ELEV | Elevation Oncology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Venbio Global Strategic Fund Iii, L.P. | CA | T | S | -2,898 | 4.12 | 0 | -703 | -27 | 1,905 | D | |||||||||||||||
10/25/21 19:40 | 10/25/21 | VTYX | Ventyx Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Venbio Global Strategic Fund Iii, L.P. | CA | TH | See Rema | P.d | 5,000 | 16.00 | 0 | 313 | 7 | 5,012 | D | ||||||||||||||
7/1/21 17:27 | 6/29/21 | ELEV | Elevation Oncology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Venbio Global Strategic Fund Iii, L.P. | CA | T | P.d | 10,000 | 16.00 | 0 | 625 | 32 | 2,608 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |